Literature DB >> 6993154

Development of program-controlled portable insulin delivery devices.

K Prestele, M Franetzki, H Kresse.   

Abstract

Various alternatives for program-controlled insulin delivery systems, on which we have been working since 1972, are described. Fixed-programmable and demand-programmable devices, both in two parts comprising separate control and delivery units, have been miniaturized and technically improved to the extent that they can now be used for the ambulant, long-term treatment of diabetic patients. The electronic drive systems, including control and safety circuits, that are discussed using the demand-type system as an example have been conventionally designed, using CMOS technology. The mechanical components of the insulin-delivery devices, in particular the roller pump driven by a stepping motor, have been developed in such a way that they can also be employed in implantable devices, without any essential modifications. Particular attention was thus paid to the features of miniaturization, high insulin concentration, low energy consumption, and a high degree of safety and reliability. The experience obtained from broad-based clinical trials of the devices is summarized briefly.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6993154     DOI: 10.2337/diacare.3.2.362

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  4 in total

Review 1.  Status of pancreatic transplants and mechanical devices for blood glucose control in diabetes.

Authors:  J V Santiago; N H White
Journal:  Ann Biomed Eng       Date:  1980       Impact factor: 3.934

2.  Chemical stability of insulin in a delivery system environment.

Authors:  U Grau
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

3.  Insulin precipitation in artificial infusion devices.

Authors:  D E James; A B Jenkins; E W Kraegen; D J Chisholm
Journal:  Diabetologia       Date:  1981-12       Impact factor: 10.122

4.  Glucose control in mobile type 1 (insulin-dependent) diabetic patients by means of a semi-automatic feedback controlled insulin infusion system.

Authors:  K Piwernetz; R Renner; K D Hepp
Journal:  Diabetologia       Date:  1982-09       Impact factor: 10.122

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.